
Coya Therapeutics, Inc.
Coya Therapeutics, Inc. (COYA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · COYA · as of Jun 8, 2026
Key Statistics
Explore Coya Therapeutics, Inc. Data
coya stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 5 · Buy rate: 100.0%
The COYA analyst consensus is Buy, based on ratings from 5 Wall Street analysts over the past 3 months. The average 12-month price target is $12.00, representing +164.32% upside from the current price of $4.54.
Competitors & Peers
coya competitorsStock Performance
Full HistoryAbout Coya Therapeutics, Inc.
Coya Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing innovative therapeutic agents that fine-tune the function of regulatory T cells (Tregs). Its therapeutic pipelin…
what is coya therapeutics, inc. · coya stock overview · coya therapeutics, inc. company profile · who is coya therapeutics, inc. ceo · coya NASDAQ · coya therapeutics, inc. headquarters · coya therapeutics, inc. business segments
About Stock Overview & Key Data
Coya Therapeutics, Inc. (COYA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Dec 29, 2022. As of the latest trading session, COYA stock price is $4.54, with a market capitalization of $82.8M. The stock has returned -22.62% over the past 12 months and -21.55% year-to-date.
According to 5 Wall Street analysts, the consensus rating for Coya Therapeutics, Inc. stock is Buy, with an average 12-month price target of $12.00. In fiscal year 2025, Coya Therapeutics, Inc. reported revenue of $7.9M and net income of -$21.2M. For detailed data — including Coya Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Coya Therapeutics, Inc. (COYA) stock price is $4.54. The stock is traded on NASDAQ under the ticker symbol COYA. The 52-week range is $3.71 – $7.75.